About: Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology
Creator	Bowdish, Dawn Nair, Parameswaran Bhalla, Anurag Mukherjee Phd, Manali Nazy Phd, Ishac Radford Msc, Katherine Rrt, Melanie
source	Medline; PMC
abstract	There is paucity of evidence assessing immune responses to COVID‐19 in severe asthmatics treated with biologics. Recent guidelines recommend continuing these agents (as clinically indicated) to maintaining asthma control. Supporting this claim, Lommatzsch demonstrated that omalizumab could safely be continued during active COVID‐19 infection in a patient with allergic asthma.(1) There are other emerging reports that show that treatment with benralizumab(2) and dupilumab(3) is not associated with significant negative impact. We had similar experience in a young patient with severe asthma treated with dupilumab.
has issue date	2020-08-06(xsd:dateTime)
bibo:doi	10.1111/all.14534
bibo:pmid	32767400
has license	no-cc
sha1sum (hex)	136c0799e0d280140b045c6e5e97420909d21eac
schema:url	https://doi.org/10.1111/all.14534
resource representing a document's title	Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology
has PubMed Central identifier	PMC7436521
has PubMed identifier	32767400
schema:publication	Allergy
resource representing a document's body	covid:136c0799e0d280140b045c6e5e97420909d21eac#body_text
is schema:about of	named entity 'Serology' named entity 'RBD' named entity 'humoral immune responses' named entity 'Sputum' named entity 'Airway' named entity 'allergic asthma' named entity 'steroid' named entity 'IgM' named entity 'TMPRSS2' named entity 'immunoglobulin' named entity 'mucus hypersecretion' named entity 'T-cell' named entity 'antigens' named entity 'TMPRSS2' named entity 'asthma' named entity 'loading dose' named entity 'Bio-Rad' named entity 'dupilumab' named entity 'asthma' named entity 'SARS-CoV2' named entity 'IL-13' named entity 'eosinophils' named entity 'infection' named entity 'asthma' named entity 'SARS-CoV2' named entity 'formoterol' named entity 'viral culture' named entity 'protein' named entity 'virus' named entity 'ACE2' named entity 'control patients' named entity 'vaccines' named entity 'GAPDH' named entity 'eosinopenia' named entity 'Teva' named entity 'dexamethasone' named entity 'index patient' named entity 'omalizumab' named entity 'COVID-19' named entity 'Lommatzsch' named entity 'spirometry' named entity 'asthma' named entity 'asthmatic' named entity 'PCR' named entity 'immune responses' named entity 'nasopharyngeal' named entity 'IL-4' named entity 'Teva' named entity 'RT-PCR' named entity 'mometasone' named entity 'biologics' named entity 'clinicaltrials.gov' named entity 'housekeeping gene' named entity 'Novartis' named entity 'IgG' named entity 'dupilumab' named entity 'SARS-CoV2' named entity 'fluticasone' named entity 'IgA' named entity 'Inhaled steroids' named entity 'antibody response' named entity 'infection' named entity 'dupilumab' named entity 'antibody' named entity 'antigens' named entity 'index patient' named entity 'meningococcal' named entity 'TMPRSS2' named entity 'infection' named entity 'Sanofi' named entity 'IgA antibodies' named entity 'infection' named entity 'virus' named entity 'T-cell' named entity 'dupilumab'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software